Amprologix

Plymouth, United Kingdom · Founded 2018 · Privately Held (backing)

Developer of antimicrobial-resistant drugs designed to combat drug-resistant infections. Amprologix is based in Plymouth, United Kingdom and was founded in 2018. Its last reported valuation was $10.9 million in Oct 2025. It has raised $1 million.

Last reported valuation

$10.9M

Oct 2026

Priced at

—

Total raised

$1.0M

Last round

—

How much has Amprologix raised?

$1.0Macross 0 recorded rounds

Free account

More of Amprologix with a free account

·Watch Amprologix: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Amprologix investors

5 investors are on record for Amprologix, including MassChallenge, UK Research and Innovation, Plutus Investment Group and Ingenza.

For fundraisers

Raising for a company like Amprologix?

5 investors have backed Amprologix.

See all 5 investors →

Frequently asked about Amprologix

How much has Amprologix raised?: Amprologix has raised $1.0M in total across 0 recorded funding rounds.